Top-News
Werbung

Attraktive Knock-Outs auf Moderna Inc

Typ Hebel Bid / Ask WKN
Call
5,1 2,22 € / 2,28 €
SW9WF9
Call
9,9 1,05 € / 1,11 €
SW9XZD
Typ Hebel Bid / Ask WKN
Put
5,0 2,34 € / 2,40 €
SV365J
Put
10,5 1,06 € / 1,12 €
SV8PRN
Den Basisprospekt sowie endgültige Bedingungen und Basisinformationsblätter erhalten Sie bei Klick auf das Dokument-Icon. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
Alle Knock-Outs auf Moderna Inc
Professionelle Dienstleistungen USA

Moderna Inc News

Aktie
WKN:  A2N9D9 ISIN:  US60770K1079 US-Symbol:  MRNA
114,02 €
-1,10 €
-0,96%
08:10:06 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
382,88 Mio.
Marktkapitalisierung *
43,57 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
Nasdaq 100
IR-Website
zur Website
*Stand: 11.04.2024

Unternehmensmeldungen

03.05.24 - Société Générale
Moderna – Ausbruch nach Zahlen
Die Moderna -Aktie (WKN: A2N9D9) hatte nach einer dynamischen Hausse im August 2021 ein Rekordhoch bei 497,49 USD markiert. Seither hatten die Bären übergeordnet das ...  Mehr »
08.09.22 - DGAP
Moderna, Inc.: Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day
DGAP-News: Moderna, Inc. / Key word(s): Miscellaneous Moderna, Inc.: Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day 08.09.2022 / 13:00 CET/CEST ...
01.09.22 - DGAP
EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of Moderna's Omicron-Targeting Bivalent Booster in the European Union
DGAP-News: Moderna, Inc. / Key word(s): Miscellaneous EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for ...
29.08.22 - DGAP
Moderna, Inc.: Swissmedic Authorizes Moderna’s Omicron-Targeting Bivalent Booster Candidate, MRNA-1273.214
DGAP-News: Moderna, Inc. / Key word(s): Miscellaneous Moderna, Inc.: Swissmedic Authorizes Moderna’s Omicron-​Targeting Bivalent Booster Candidate, MRNA-1273.214 ...
15.08.22 - DGAP
Medicines and Healthcare Products Regulatory Agency (MHRA) Authorizes Moderna's Omicron-Containing Bivalent Booster in the UK
DGAP-News: Moderna, Inc. / Key word(s): Miscellaneous Medicines and Healthcare Products Regulatory Agency (MHRA) Authorizes Moderna's Omicron-​Containing Bivalent Booster ...
09.08.22 - DGAP
Moderna And the European Commission (EC) Amend Covid-19 Vaccine Agreement to Supply Omicron-Containing Bivalent Candidates; EC Purchases Additional 15 million Doses
DGAP-News: Moderna, Inc. / Key word(s): Miscellaneous Moderna And the European Commission (EC) Amend Covid-19 Vaccine Agreement to Supply Omicron-​Containing Bivalent ...
22.07.22 - DGAP
EMA Committee for Medicinal Products for Human Use (CHMP) Recommends Use of the Moderna COVID-19 Booster in Adolescents (12-17 Years) in the European Union
DGAP-News: Moderna, Inc. / Key word(s): Miscellaneous EMA Committee for Medicinal Products for Human Use (CHMP) Recommends Use of the Moderna COVID-19 Booster in ...
02.06.22 - DGAP
Moderna and the European Commission Agree on Amendment to COVID-19 Vaccine Supply Agreement
DGAP-News: Moderna, Inc. / Key word(s): Miscellaneous Moderna and the European Commission Agree on Amendment to COVID-19 Vaccine Supply Agreement 02.06.2022 / 13:00 ...
29.04.22 - DGAP
Moderna Files to Expand Conditional Marketing Authorization for Its COVID-19 Vaccine to Include Children Six Months to Under Six Years in The European Union
DGAP-News: Moderna, Inc. / Key word(s): Miscellaneous Moderna Files to Expand Conditional Marketing Authorization for Its COVID-19 Vaccine to Include Children Six Months to ...
21.03.22 - DGAP
Moderna Announces New Supply Agreement for 2023 with Switzerland for Additional Seven Million Doses of Moderna's COVID-19 Booster Vaccine
DGAP-News: Moderna, Inc. / Key word(s): Agreement Moderna Announces New Supply Agreement for 2023 with Switzerland for Additional Seven Million Doses of Moderna's COVID-...
24.02.22 - DGAP
EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for The Use of The Moderna Covid-19 Vaccine in Children (6-11 Years) In the European Union
DGAP-News: Moderna, Inc. / Key word(s): Miscellaneous EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for ...
17.02.22 - DGAP
Moderna, Inc.: Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years)
DGAP-News: Moderna, Inc. / Key word(s): Miscellaneous Moderna, Inc.: Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 ...
16.02.22 - DGAP
Moderna and ROVI Expand Long-term Collaboration for the Manufacture of MRNA Medicines Over the Next Ten Years
DGAP-News: Moderna, Inc. / Key word(s): Agreement Moderna and ROVI Expand Long-term Collaboration for the Manufacture of MRNA Medicines Over the Next Ten Years ...
07.01.21 - DGAP
Corona-Impfstoff des US-Herstellers Moderna ist in der EU zugelassen
DGAP-​Media / 07.01.2021 / 13:17
24.09.20 - DGAP
Sweet Earth: Exklusiver Liefervertrag für CBD Hundeprodukte: Vertrieb über große E-Commerce Plattform bringt Umsatzwachstum - Kaufempfehlung!
DGAP-​Media / 24.09.2020 / 08:24
10.08.20 - DGAP
Meguma Gold Corp.: Übernahmekandidat Nr. 1 im Goldsektor: Großes Explorationsprogramm kurz vor Beginn - Wann reagiert der große Nachbar?
DGAP-​Media / 10.08.2020 / 09:16
29.07.20 - DGAP
Sweet Earth: Shark Tank Investor setzt auf diese CBD-Produkte - Aktie vor Neubewertung!
DGAP-​Media / 29.07.2020 / 09:19
07.07.20 - DGAP
Sweet Earth: Expansion nach Europa - Hanfanbau in Spanien in den Startlöchern!
DGAP-​Media / 07.07.2020 / 09:22
29.06.20 - DGAP
Sweet Earth: Bedeutende US-Handelskette mit Liefervertrag für CBD-Desinfektionsmittel - Aktie unter Buchwert und vor Millionenumsätzen!
DGAP-​Media / 29.06.2020 / 09:16
22.06.20 - DGAP
Sweet Earth: CBD-Player schließt gigantischen Millionendeal mit bedeutender E-Commerce Plattform!
DGAP-​Media / 22.06.2020 / 09:30
11.06.20 - DGAP
Sweet Earth: CBD-Newcomer mit gigantischem Potenzial sichert sich NFL-Star als Markensprecher!
DGAP-​Media / 11.06.2020 / 10:01

Newssuche

Videos

07.05.24 +17,87%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »